In line with our initial hypotheses, combined treatment with PEDF and NFκB inhibitor reduced colony formation, and therefore anchorage-independent growth of ER+/HER2- BC cells under post-menopausal oestrogen conditions. The gene discussed is NFKB1; the disease is breast cancer.